Horizon 3

Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.

ChainCraft is a company focused on mixed culture fermentation technology aimed at producing sustainable bio-based chemicals for the chemical, food, and feed industries. Their innovative approach utilizes waste mitigation services to convert low-grade organic residues, such as food waste, agricultural byproducts, and the organic fraction of municipal solid waste, into high-value fatty acids. By transforming biobased organic waste streams into valuable chemical building blocks, ChainCraft offers a competitive alternative to traditional industry-produced chemicals, promoting environmental sustainability and resource efficiency in the chemical industry.

ChainCraft is a company focused on mixed culture fermentation technology aimed at producing sustainable bio-based chemicals for the chemical, food, and feed industries. Their innovative approach utilizes waste mitigation services to convert low-grade organic residues, such as food waste, agricultural byproducts, and the organic fraction of municipal solid waste, into high-value fatty acids. By transforming biobased organic waste streams into valuable chemical building blocks, ChainCraft offers a competitive alternative to traditional industry-produced chemicals, promoting environmental sustainability and resource efficiency in the chemical industry.